Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

19:56 EST 22nd November 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,500+

Wednesday 19th November 2014

Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic

BOTHELL, WA -- (Marketwired) -- 11/20/14 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported that its partner, Mirna Therapeutics, presented interim safety and preliminary efficacy data from a multicenter, open-label Phase 1 clinical trial of MRX34. MRX34 is a microRNA34 mimic formulated in the Company...

TSRI researchers find how mutant gene can cause deafness

(Scripps Research Institute) Scientists at the Scripps Research Institute have discovered how one gene is essential to hearing, uncovering a cause of deafness and suggesting new avenues for therapies.

REMINDER: Canadian Achievements in Health Research & Innovation Honoured at Rx&D Health Research Foundation Awards Ceremony

TORONTO, ONTARIO -- (Marketwired) -- 11/20/14 -- Editors Note: There is a photo associated with this Press Release. At a celebration honouring the greatest Canadian innovations in health research, the Rx&D Health Research Foundation (HRF) has awarded its Medal of Honour to Dr. Robert Young and Dr. Charles Tator for their incredible achievements in Canadian health science and clinical and res...

Salk scientists unveil powerful method to speed cancer drug discovery

(Salk Institute) The new method lets researchers identify weak and previously undetectable interactions between proteins inside living cells.

SGI-DNA Launches Gibson Assembly Hifi 1 Step Kit For Simple, Seamless And Rapid Construction Of Synthetic Genes, Gene Clusters And Genetic Pathways

LA JOLLA, Calif., Nov. 20, 2014 /PRNewswire/ -- SGI-DNA announces the launch of the Gibson Assembly HiFi 1 Step Kit which allows researchers to assemble multiple, large DNA fragments in a simple one hour, one-step reaction. This is the first high fidelity kit on the market using the Gibson Assembly method...

Theravance Biopharma to Host Investor and Analyst Day on December 12th

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/20/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. operating subsidiary, Theravance Biopharma US, Inc., that the Company will host an Investor and Analyst Day for the investment community on Friday, December 12, 2014 from 8:30 am to 11:30 am EST in New York, NY. Management w...

Caltech, City of Hope Collaborate to Advance Scientific Breakthroughs, Medical Research

New agreement expands access to resources, educational opportunities and scientific cooperation A new agreement between City of Hope and California Institute of Technology will foster greater collaboration between some of the most innovative thinkers in technology, medicine and science. A new memorandum of understanding, signed by Thomas F. Ro...

Phase 1 Dose Escalation Data for Epizyme EZH2 Inhibitor EPZ-6438 (E7438) Shows Single Agent Activity in B-Cell Non-Hodgkin Lymphomas and Malignant Rhabdoid Tumor

Partial response or better seen in four of 10 evaluable patients with relapsed or refractory non-Hodgkin lymphoma (NHL), including three of five evaluable patients with diffuse large B-cell lymphoma (DLBCL) Ongoing complete response observed in one DLBCL patient Ongoing partial res...

Gene therapy found effective in hemophilia B

(Reuters Health) - Ten patients with severe hemophilia B have remained cured of the inherited bleeding disorder for as long as three years thanks to gene therapy, according to a new report on the technique in the New England Journal of Medicine.

New Computer Model Sets New Precedent in Drug Discovery

( – Merging expertise from computer science and synthetic drug design, the new model reveals that the drug efficacy of fusion-protein therapies depends on the geometric characteristics of a drug’s molecular components. Use of the...

UCLA Researchers Announce Gene Therapy Cure for 18 ‘Bubble Baby’ Patients

(ABC News) – Researchers at UCLA announced today that they had cured 18 children who were born with the so-called Bubble Baby disease, a genetic disorder that leaves the young sufferers without a working immune system, putting them at risk R...

Delivery of Stem Cells into Heart Muscle After Heart Attack May Enhance Cardiac Repair and Reverse Injury

Study Findings by Icahn School of Medicine at Mount Sinai Presented at the American Heart Association Scientific Sessions 2014 New York, NY (PRWEB) November 19, 2014 Delivering stem cell factor directly into damaged heart muscle after a heart attack may help repair and regenerate injured tissue, according to a study led by researchers from Icahn School of Medicine at Mount Sinai presented Novembe...

Gene therapy provides safe, long-term relief for patients with severe hemophilia B

MEMPHIS, Tenn., Nov. 19, 2014 /PRNewswire-USNewswire/ -- Gene therapy developed at St. Jude Children's Research Hospital, University College London (UCL) and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported....

Stanford researchers compare mammals' genomes to aid human clinical research

For years, scientists have considered the laboratory mouse one of the best models for researching disease in humans because of the genetic similarity between the two mammals. Now, researchers at the Stanford University School of Medicine have found t...

CF Foundation sells royalty rights for $3.3B

Royalty Pharma (New York, N.Y.) paid $3.3 billion to acquire the Cystic Fibrosis Foundation's rights to royalties from cystic fibrosis (CF) treatments developed by Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). The deal includes royalties from Kalydeco

3-D-Printed Human Liver Tissues Can Benefit Preclinical Testing

The three-dimensional biology company Organovo Holdings Inc. announced the full commercial release of the exVive3D Human Liver Tissue for preclinical drug discovery testing. Initially, clients will be able to access the technology through Organovo's contract research services program. This model is intended to provide human-specific data to aid in the prediction of liver tissue toxicity or ADME ou...

Bone Therapeutics, Kasios ally in spine fusion

In a two-year collaboration, Bone Therapeutics SA (gene therapies) and Kasios (synthetic bone substitutes) will combine products to create a new approach for spinal fusion.

Scientist finds marker that predicts cholesterol level changes as people grow older

It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recen...

Maximizing the Power of Preclinical Cancer Research Tools

Drug discovery is a protracted and uncertain process that needs to overcome many hurdles during preclinical and clinical development before it finally achieves regulatory approval for patient treatment. For every drug that reaches the marketplace, well over 100 have been abandoned at some point in their development.

Illumina teams with U.S. government, researchers to sequence Ebola

CHICAGO (Reuters) - Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in...

Lexicon Announces Proposed Common Stock Offering

THE WOODLANDS, Texas, Nov. 19, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it commenced an offering to sell, subject to market and other conditions, $50,000,000 of shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.  Lexicon also intends to grant the underwriters a 30-day option to...

Next Generation Sequencing (NGS) Market worth $8.7 Billion by 2020 - New Report by MarketsandMarkets

The NGS platforms market will be dominated by Illumina in 2014, which will occupy the largest market share of 74%. (PRWEB) November 19, 2014 The “Next Generation Sequencing (NGS) Market by Bioinformatics (Exome Sequencing, RNA-Seq, ChIP-Seq), Technology (SBS, SMRT), Platforms (Illumina H...

Biothera Names Dr. Jeremy Graff SVP of Pharmaceutical Research

Biothera announced today the appointment of Jeremy R. Graff, Ph.D., as Senior Vice President, Research, for its Pharmaceutical Group. Most recently, Dr. Graff served as a Research Fellow and Group Leader, Oncology Patient Tailoring at Eli Lilly and Company.

efg&m, L.P. Announces Strategic Partnership with Maxwell Health

AUSTIN, Texas, Nov. 19, 2014 /PRNewswire/ -- efg&m, L.P., a locally owned and operated independent insurance brokerage firm based in Austin and Round Rock announced a strategic partnership today with Maxwell Health to provide a comprehensive operating system for employee benefits to their clients. Maxwell's mobile-enabled platform simplifies benefits enrollment and administration, provides cen...

American Psychiatric Publishing Re-launches PsychiatryOnline with Atypon

Atypon®, a leading provider of software to the scientific and scholarly publishing industry, and American Psychiatric Publishing (APP), a division of American Psychiatric Association, have re-launched PsychiatryOnline on Atypon’s Literatum platform. PsychiatryOnline features DSM-5®— the most widely used psychiatric reference in the world

Search BioPortfolio:

News Quicklinks